Global In-Vitro Diagnostic Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by In-Vitro Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global In-Vitro Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Disposable IVD Devices
  • 1.4.3 Reusable IVD Devices
• 1.5 Market by Application
  • 1.5.1 Global In-Vitro Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Clinics
  • 1.5.3 Diagnostic Center
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global In-Vitro Diagnostic Market Perspective (2015-2026)
• 2.2 Global In-Vitro Diagnostic Growth Trends by Regions
  • 2.2.1 In-Vitro Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 In-Vitro Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 In-Vitro Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 In-Vitro Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key In-Vitro Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top In-Vitro Diagnostic Players by Market Size
  • 3.1.1 Global Top In-Vitro Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global In-Vitro Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global In-Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global In-Vitro Diagnostic Market Concentration Ratio
  • 3.2.1 Global In-Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostic Revenue in 2019
• 3.3 In-Vitro Diagnostic Key Players Head office and Area Served
• 3.4 Key Players In-Vitro Diagnostic Product Solution and Service
• 3.5 Date of Enter into In-Vitro Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global In-Vitro Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global In-Vitro Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global In-Vitro Diagnostic Market Size by Application (2015-2020)
• 5.2 Global In-Vitro Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America In-Vitro Diagnostic Market Size (2015-2020)
• 6.2 In-Vitro Diagnostic Key Players in North America (2019-2020)
• 6.3 North America In-Vitro Diagnostic Market Size by Type (2015-2020)
• 6.4 North America In-Vitro Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe In-Vitro Diagnostic Market Size (2015-2020)
• 7.2 In-Vitro Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe In-Vitro Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe In-Vitro Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China In-Vitro Diagnostic Market Size (2015-2020)
• 8.2 In-Vitro Diagnostic Key Players in China (2019-2020)
• 8.3 China In-Vitro Diagnostic Market Size by Type (2015-2020)
• 8.4 China In-Vitro Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan In-Vitro Diagnostic Market Size (2015-2020)
• 9.2 In-Vitro Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan In-Vitro Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan In-Vitro Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia In-Vitro Diagnostic Market Size (2015-2020)
• 10.2 In-Vitro Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia In-Vitro Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia In-Vitro Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India In-Vitro Diagnostic Market Size (2015-2020)
• 11.2 In-Vitro Diagnostic Key Players in India (2019-2020)
• 11.3 India In-Vitro Diagnostic Market Size by Type (2015-2020)
• 11.4 India In-Vitro Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America In-Vitro Diagnostic Market Size (2015-2020)
• 12.2 In-Vitro Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America In-Vitro Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America In-Vitro Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott In-Vitro Diagnostic Introduction
  • 13.1.4 Abbott Revenue in In-Vitro Diagnostic Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Johnson and Johnson
  • 13.2.1 Johnson and Johnson Company Details
  • 13.2.2 Johnson and Johnson Business Overview
  • 13.2.3 Johnson and Johnson In-Vitro Diagnostic Introduction
  • 13.2.4 Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.2.5 Johnson and Johnson Recent Development
• 13.3 BD
  • 13.3.1 BD Company Details
  • 13.3.2 BD Business Overview
  • 13.3.3 BD In-Vitro Diagnostic Introduction
  • 13.3.4 BD Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.3.5 BD Recent Development
• 13.4 Danaher
  • 13.4.1 Danaher Company Details
  • 13.4.2 Danaher Business Overview
  • 13.4.3 Danaher In-Vitro Diagnostic Introduction
  • 13.4.4 Danaher Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.4.5 Danaher Recent Development
• 13.5 Thermo Fisher Scientific
  • 13.5.1 Thermo Fisher Scientific Company Details
  • 13.5.2 Thermo Fisher Scientific Business Overview
  • 13.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Introduction
  • 13.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.5.5 Thermo Fisher Scientific Recent Development
• 13.6 Bio-Rad
  • 13.6.1 Bio-Rad Company Details
  • 13.6.2 Bio-Rad Business Overview
  • 13.6.3 Bio-Rad In-Vitro Diagnostic Introduction
  • 13.6.4 Bio-Rad Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.6.5 Bio-Rad Recent Development
• 13.7 Abbott
  • 13.7.1 Abbott Company Details
  • 13.7.2 Abbott Business Overview
  • 13.7.3 Abbott In-Vitro Diagnostic Introduction
  • 13.7.4 Abbott Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.7.5 Abbott Recent Development
• 13.8 Hologic
  • 13.8.1 Hologic Company Details
  • 13.8.2 Hologic Business Overview
  • 13.8.3 Hologic In-Vitro Diagnostic Introduction
  • 13.8.4 Hologic Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.8.5 Hologic Recent Development
• 13.9 KEM-EN-TEC Diagnostics
  • 13.9.1 KEM-EN-TEC Diagnostics Company Details
  • 13.9.2 KEM-EN-TEC Diagnostics Business Overview
  • 13.9.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Introduction
  • 13.9.4 KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.9.5 KEM-EN-TEC Diagnostics Recent Development
• 13.10 Medtronic
  • 13.10.1 Medtronic Company Details
  • 13.10.2 Medtronic Business Overview
  • 13.10.3 Medtronic In-Vitro Diagnostic Introduction
  • 13.10.4 Medtronic Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 13.10.5 Medtronic Recent Development
• 13.11 Omega Diagnostics
  • 10.11.1 Omega Diagnostics Company Details
  • 10.11.2 Omega Diagnostics Business Overview
  • 10.11.3 Omega Diagnostics In-Vitro Diagnostic Introduction
  • 10.11.4 Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.11.5 Omega Diagnostics Recent Development
• 13.12 Ortho Clinical Diagnostics
  • 10.12.1 Ortho Clinical Diagnostics Company Details
  • 10.12.2 Ortho Clinical Diagnostics Business Overview
  • 10.12.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Introduction
  • 10.12.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.12.5 Ortho Clinical Diagnostics Recent Development
• 13.13 Roche
  • 10.13.1 Roche Company Details
  • 10.13.2 Roche Business Overview
  • 10.13.3 Roche In-Vitro Diagnostic Introduction
  • 10.13.4 Roche Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.13.5 Roche Recent Development
• 13.14 Siemens Healthineers
  • 10.14.1 Siemens Healthineers Company Details
  • 10.14.2 Siemens Healthineers Business Overview
  • 10.14.3 Siemens Healthineers In-Vitro Diagnostic Introduction
  • 10.14.4 Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.14.5 Siemens Healthineers Recent Development
• 13.15 Sysmex
  • 10.15.1 Sysmex Company Details
  • 10.15.2 Sysmex Business Overview
  • 10.15.3 Sysmex In-Vitro Diagnostic Introduction
  • 10.15.4 Sysmex Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.15.5 Sysmex Recent Development
• 13.16 Atlas Genetics
  • 10.16.1 Atlas Genetics Company Details
  • 10.16.2 Atlas Genetics Business Overview
  • 10.16.3 Atlas Genetics In-Vitro Diagnostic Introduction
  • 10.16.4 Atlas Genetics Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.16.5 Atlas Genetics Recent Development
• 13.17 ELITechGroup
  • 10.17.1 ELITechGroup Company Details
  • 10.17.2 ELITechGroup Business Overview
  • 10.17.3 ELITechGroup In-Vitro Diagnostic Introduction
  • 10.17.4 ELITechGroup Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.17.5 ELITechGroup Recent Development
• 13.18 Biomerieux
  • 10.18.1 Biomerieux Company Details
  • 10.18.2 Biomerieux Business Overview
  • 10.18.3 Biomerieux In-Vitro Diagnostic Introduction
  • 10.18.4 Biomerieux Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.18.5 Biomerieux Recent Development
• 13.19 Werfen
  • 10.19.1 Werfen Company Details
  • 10.19.2 Werfen Business Overview
  • 10.19.3 Werfen In-Vitro Diagnostic Introduction
  • 10.19.4 Werfen Revenue in In-Vitro Diagnostic Business (2015-2020)
  • 10.19.5 Werfen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer